01Health

Investor: Gresham House Ventures

London-headquartered healthtech company 01Health has secured a £11.2 million ($15 million) Series A funding round led by Gresham House Ventures, bringing its total capital raised to date to $25 million. Summary of transaction details: Value: £11.2 million ($15 million) Series A. Sector: Healthcare & Biotech / HealthTech / B2B SaaS. Advisor: Not disclosed. Key Entities: Target: 01Health; Lead Investor: Gresham House Ventures; Follow-on Investors: Balderton Capital, Eka Ventures, Wavemaker360; Angel Backers: Nicolas Cary (Co-Founder of Blockchain.com); Key Executive: Dr. Sonia Szamocki (Founder & CEO). Location: London, UK, with active expansion underway in the US. Note: Founded in 2022 by former NHS doctor and BCG consultant Dr. Sonia Szamocki, 01Health acts as an end-to-end infrastructure platform built for multi-site dental groups and Dental Service Organisations (DSOs). The platform is designed to decentralise clinical expertise, allowing community clinics to offer advanced, specialist lines of care without investing in massive infrastructure or on-site specialists. Until now, the company’s unified layer—which integrates AI-powered patient acquisition, standardized clinical protocols, and remote specialist oversight—has run entirely behind its own consumer brands: 32Co (the UK's top-rated clear aligner system) and Aerox Health (a dental sleep medicine platform). This transaction marks the official public commercial launch of the underlying technology layer under a standalone SaaS licensing model. The £11.2m injection will fund the commercial rollout to external practice networks, scale non-dental clinical trials, and back their US market entry, where a dedicated Head of US Commercial Operations has already been appointed.